Cheers @amb005. Good that you keep posting these across all the...

Cheers @amb005. Good that you keep posting these across all the forums to give investors a picture of what is happening in the industry.

I posted the latest data on another forum which included Fwd Funds. Not a pretty site at the moment for many companies, including LGP. I have been criticized heavily for trying to help another Cannabis company in its early growth stages, but even though it has failed at getting most of its deals up, it has managed to conserve funds and drop its expenses which is what Pennies should do in saturated markets in order to ride tough times out until profits are generated. No guarantee of success for it, though, unless it can lock something down to secure revenue.

Many of these guys must watch their expenses, as running controlled hothouses is a very expensive business when working in an over-saturated market.

In Australia, there are many private companies also vying for the same piece of the pie, which ASX investors don't see as we do with these publics. LGP needed to secure more European deals and import more products into Oz. Loans will kill many of these companies IMO, and R & D rebates can only go so far to propping up strugglers and can paint a false picture of profitability/progress.

I think the most helpful thing that many of these companies can do now is to cut the largesse out of the Senior corporate costs bringing them down to the $100 -$200K max until they turn profits.

Just to add some more data to your chart. Look at the Fund Fwd column, and you will see what I mean.